Estrella Immunopharma, Inc.

Q4 2024 13F Holders

Symbol
ESLA
CUSIP
297584104
Type
Equity
Class
COM
Num filings
12
Total reported value, excl. options
$341 k
Manager Report Date Value ($000) Shares Option Type